Open full session page

Cell-based immunomodulation and transplant tolerance: From mechanisms to long-term outcomes

Abstract Session Regenerative Medicine/Cell Tx

Presentations

Oral Presentation
08:00
HLA-Silenced Cell Therapy Enhances Donor Lung Recovery and Mitigates Primary Graft Dysfunction in a Porcine Transplant Model
Franziska Olm (SE)
Mini-Oral Presentation
08:10
Gene Editing with a Novel Binary Retroviral Vector System to Reduce HLA Class I Allogenicity
Katrin Hacke (US)
Saumadritaa Kar (CA) 08:17
Pramlintide‑expressing stem cell‑derived beta cells limit islet amyloid in a transplantation model of type 1 diabetes
Saumadritaa Kar (CA)
Audrey Au Yong (GB) 08:24
10-year malignancy outcomes following autologous polyclonal ex-vivo-expanded Treg therapy in renal transplantation
Audrey Au Yong (GB)
08:31
Driving naïve Tregs toward alloantigen memory-like Tregs using a novel expansion protocol
Xuan Han (AU)
08:38
Attenuation of Chronic Renal Allograft Rejection in Rats by Exosomes from Human induced Pluripotent Stem Cell derived Nephron Progenitor Cells
Haiwei Chen (CN)

Share this session

Cell-based immunomodulation and transplant tolerance: From mechanisms to long-term outcomes

Facebook LinkedIn X / Twitter Email
https://app.tts2026.org/program_view/timeslot/12